Skip to main content
logo
Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
86.45
+3.60 (4.35%)
Aug 20, 2026, 4:09 PM HKT

Vigonvita Life Sciences Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Market Capitalization
14,48913,718--
Market Cap Growth
----
Enterprise Value
14,62114,171--
Last Close Price
86.4581.85--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
PS Ratio
127.53120.74--
PB Ratio
29.8828.29--
P/TBV Ratio
34.4032.57--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
128.69124.73--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
1.481.483.051.71
Debt / EBITDA Ratio
---13.34
Net Debt / Equity Ratio
0.300.302.181.20
Net Debt / EBITDA Ratio
-0.41-0.41-1.6715.93
Net Debt / FCF Ratio
-0.50-0.50-1.64-4.01
Asset Turnover
0.100.100.02-
Inventory Turnover
2.602.601.11-
Quick Ratio
1.051.050.460.56
Current Ratio
1.071.070.500.58
Return on Equity (ROE)
-123.98%-123.98%-132.51%-
Return on Assets (ROA)
-20.73%-20.73%-18.15%-
Return on Capital Employed (ROCE)
-43.70%-43.70%-50.40%1.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-2.73%-2.89%--
FCF Yield
-1.97%-2.08%--
Buyback Yield / Dilution
--4.87%-0.69%-